With ‘bold experiment’ in drug pricing, Arcutis aims to stand out in plaque psoriasis – MedCity News
FDA approval of Arcutis Biotherapeutics’ new drug for plaque psoriasis allows the company to implement a strategy it believes will win both payers and patients — lower prices. Arcutis has…